메뉴 건너뛰기




Volumn 2, Issue 2, 2010, Pages 58-64

Surgery and chemotherapy for intrahepatic cholangiocarcinoma

Author keywords

Chemotherapy; Intrahepatic cholangiocarcinoma; Surgery

Indexed keywords


EID: 79959944883     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v2.i2.58     Document Type: Article
Times cited : (62)

References (75)
  • 1
    • 0003675495 scopus 로고    scopus 로고
    • Tumors of the liver and intrahepatic bile ducts
    • (Atlas of Tumor Pathology, 3rd series, Fascicle 31.) Washington DC: Armed Forces Institute of Pathology
    • Ishak KG, Goodman ZD, Stocker JT. Tumors of the liver and intrahepatic bile ducts. (Atlas of Tumor Pathology, 3rd series, Fascicle 31.) Washington DC: Armed Forces Institute of Pathology; 2001
    • (2001)
    • Ishak, K.G.1    Goodman, Z.D.2    Stocker, J.T.3
  • 4
    • 0034982536 scopus 로고    scopus 로고
    • Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States
    • Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001; 33: 1353-1357
    • (2001) Hepatology , vol.33 , pp. 1353-1357
    • Patel, T.1
  • 7
    • 21344459308 scopus 로고    scopus 로고
    • The role of chemotherapy in cholangiocarcinoma
    • Thongprasert S. The role of chemotherapy in cholangiocarcinoma. Ann Oncol 2005; 16 Suppl 2: ii93-ii96
    • (2005) Ann Oncol , vol.16 , Issue.SUPPL. 2
    • Thongprasert, S.1
  • 9
    • 0029794696 scopus 로고    scopus 로고
    • Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy
    • discussion 520-522
    • Bismuth H, Adam R, Lévi F, Farabos C, Waechter F, Castaing D, Majno P, Engerran L. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996; 224: 509-520; discussion 520-522
    • (1996) Ann Surg , vol.224 , pp. 509-520
    • Bismuth, H.1    Adam, R.2    Lévi, F.3    Farabos, C.4    Waechter, F.5    Castaing, D.6    Majno, P.7    Engerran, L.8
  • 10
    • 15744374738 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma
    • Leonard GD, Brenner B, Kemeny NE. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 2005; 23: 2038-2048
    • (2005) J Clin Oncol , vol.23 , pp. 2038-2048
    • Leonard, G.D.1    Brenner, B.2    Kemeny, N.E.3
  • 11
    • 34548695686 scopus 로고    scopus 로고
    • Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma
    • Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T, Ojima H. Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma. World J Surg 2007; 31: 2016-2022
    • (2007) World J Surg , vol.31 , pp. 2016-2022
    • Shimada, K.1    Sano, T.2    Sakamoto, Y.3    Esaki, M.4    Kosuge, T.5    Ojima, H.6
  • 12
    • 34347334558 scopus 로고    scopus 로고
    • Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type
    • Aishima S, Kuroda Y, Nishihara Y, Iguchi T, Taguchi K, Taketomi A, Maehara Y, Tsuneyoshi M. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type. Am J Surg Pathol 2007; 31: 1059-1067
    • (2007) Am J Surg Pathol , vol.31 , pp. 1059-1067
    • Aishima, S.1    Kuroda, Y.2    Nishihara, Y.3    Iguchi, T.4    Taguchi, K.5    Taketomi, A.6    Maehara, Y.7    Tsuneyoshi, M.8
  • 13
    • 0035498610 scopus 로고    scopus 로고
    • A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables
    • Okabayashi T, Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Takayama T, Makuuchi M. A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 2001; 92: 2374-2383
    • (2001) Cancer , vol.92 , pp. 2374-2383
    • Okabayashi, T.1    Yamamoto, J.2    Kosuge, T.3    Shimada, K.4    Yamasaki, S.5    Takayama, T.6    Makuuchi, M.7
  • 19
    • 0026336756 scopus 로고
    • Intrahepatic cholangiocarcinoma: clinical aspects, pathology and treatment
    • discussion 101-102
    • Schlinkert RT, Nagorney DM, Van Heerden JA, Adson MA. Intrahepatic cholangiocarcinoma: clinical aspects, pathology and treatment. HPB Surg 1992; 5: 95-101; discussion 101-102
    • (1992) HPB Surg , vol.5 , pp. 95-101
    • Schlinkert, R.T.1    Nagorney, D.M.2    Van Heerden, J.A.3    Adson, M.A.4
  • 23
    • 0031942312 scopus 로고    scopus 로고
    • Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases
    • Madariaga JR, Iwatsuki S, Todo S, Lee RG, Irish W, Starzl TE. Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg 1998; 227: 70-79
    • (1998) Ann Surg , vol.227 , pp. 70-79
    • Madariaga, J.R.1    Iwatsuki, S.2    Todo, S.3    Lee, R.G.4    Irish, W.5    Starzl, T.E.6
  • 28
    • 0032415443 scopus 로고    scopus 로고
    • Prospective randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C for non-resectable pancreatic and biliary carcinoma: multicenter randomized trial
    • Takada T, Nimura Y, Katoh H, Nagakawa T, Nakayama T, Matsushiro T, Amano H, Wada K. Prospective randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C for non-resectable pancreatic and biliary carcinoma: multicenter randomized trial. Hepatogastroenterology 1998; 45: 2020-2026
    • (1998) Hepatogastroenterology , vol.45 , pp. 2020-2026
    • Takada, T.1    Nimura, Y.2    Katoh, H.3    Nagakawa, T.4    Nakayama, T.5    Matsushiro, T.6    Amano, H.7    Wada, K.8
  • 29
    • 0027935148 scopus 로고
    • Comparison of 5-fluorouracil, doxorubicin and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinomas
    • Takada T, Kato H, Matsushiro T, Nimura Y, Nagakawa T, Nakayama T. Comparison of 5-fluorouracil, doxorubicin and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinomas. Oncology 1994; 51: 396-400
    • (1994) Oncology , vol.51 , pp. 396-400
    • Takada, T.1    Kato, H.2    Matsushiro, T.3    Nimura, Y.4    Nagakawa, T.5    Nakayama, T.6
  • 30
    • 9544221631 scopus 로고    scopus 로고
    • Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.)
    • Gebbia V, Majello E, Testa A, Pezzella G, Giuseppe S, Giotta F, Riccardi F, Fortunato S, Colucci G, Gebbia N. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.). Cancer 1996; 78: 1300-1307
    • (1996) Cancer , vol.78 , pp. 1300-1307
    • Gebbia, V.1    Majello, E.2    Testa, A.3    Pezzella, G.4    Giuseppe, S.5    Giotta, F.6    Riccardi, F.7    Fortunato, S.8    Colucci, G.9    Gebbia, N.10
  • 32
    • 0031817576 scopus 로고    scopus 로고
    • Weekly 24 h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract carcinomas
    • Chen JS, Jan YY, Lin YC, Wang HM, Chang WC, Liau CT. Weekly 24 h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract carcinomas. Anticancer Drugs 1998; 9: 393-397
    • (1998) Anticancer Drugs , vol.9 , pp. 393-397
    • Chen, J.S.1    Jan, Y.Y.2    Lin, Y.C.3    Wang, H.M.4    Chang, W.C.5    Liau, C.T.6
  • 34
    • 0037391166 scopus 로고    scopus 로고
    • Prospective evaluation of efficacy and toxicity of 5-fu and folinic acid (Mayo Clinic regimen) in patients with advanced cancer of the gallbladder
    • Malik IA, Aziz Z. Prospective evaluation of efficacy and toxicity of 5-fu and folinic acid (Mayo Clinic regimen) in patients with advanced cancer of the gallbladder. Am J Clin Oncol 2003; 26: 124-126
    • (2003) Am J Clin Oncol , vol.26 , pp. 124-126
    • Malik, I.A.1    Aziz, Z.2
  • 38
    • 0037971086 scopus 로고    scopus 로고
    • A phase II trial of gemcitabine in the treatment of advanced bile duct and periampullary carcinomas
    • Lin MH, Chen JS, Chen HH, Su WC. A phase II trial of gemcitabine in the treatment of advanced bile duct and periampullary carcinomas. Chemotherapy 2003; 49: 154-158
    • (2003) Chemotherapy , vol.49 , pp. 154-158
    • Lin, M.H.1    Chen, J.S.2    Chen, H.H.3    Su, W.C.4
  • 42
    • 49749136654 scopus 로고    scopus 로고
    • S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study
    • Furuse J, Okusaka T, Boku N, Ohkawa S, Sawaki A, Masumoto T, Funakoshi A. S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study. Cancer Chemother Pharmacol 2008; 62: 849-855
    • (2008) Cancer Chemother Pharmacol , vol.62 , pp. 849-855
    • Furuse, J.1    Okusaka, T.2    Boku, N.3    Ohkawa, S.4    Sawaki, A.5    Masumoto, T.6    Funakoshi, A.7
  • 43
    • 10844293439 scopus 로고    scopus 로고
    • Phase II study of S-1 in patients with advanced biliary tract cancer
    • Ueno H, Okusaka T, Ikeda M, Takezako Y, Morizane C. Phase II study of S-1 in patients with advanced biliary tract cancer. Br J Cancer 2004; 91: 1769-1774
    • (2004) Br J Cancer , vol.91 , pp. 1769-1774
    • Ueno, H.1    Okusaka, T.2    Ikeda, M.3    Takezako, Y.4    Morizane, C.5
  • 44
    • 0027182199 scopus 로고
    • Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group Study
    • Taal BG, Audisio RA, Bleiberg H, Blijham GH, Neijt JP, Veenhof CH, Duez N, Sahmoud T. Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group Study. Ann Oncol 1993; 4: 607-609
    • (1993) Ann Oncol , vol.4 , pp. 607-609
    • Taal, B.G.1    Audisio, R.A.2    Bleiberg, H.3    Blijham, G.H.4    Neijt, J.P.5    Veenhof, C.H.6    Duez, N.7    Sahmoud, T.8
  • 47
    • 0021717017 scopus 로고
    • 5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract
    • Harvey JH, Smith FP, Schein PS. 5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract. J Clin Oncol 1984; 2: 1245-1248
    • (1984) J Clin Oncol , vol.2 , pp. 1245-1248
    • Harvey, J.H.1    Smith, F.P.2    Schein, P.S.3
  • 48
    • 0028214029 scopus 로고
    • Epirubicin-sequential methotrexate- 5-fluorouracil-leucovorin treatment in advanced cancer of the extrahepatic biliary system. A Phase II study
    • Kajanti M, Pyrhönen S. Epirubicin-sequential methotrexate- 5-fluorouracil-leucovorin treatment in advanced cancer of the extrahepatic biliary system. A Phase II study. Am J Clin Oncol 1994; 17: 223-226
    • (1994) Am J Clin Oncol , vol.17 , pp. 223-226
    • Kajanti, M.1    Pyrhönen, S.2
  • 49
    • 0035018806 scopus 로고    scopus 로고
    • Mitomycin C with weekly 24-h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract and periampullar carcinomas
    • Chen JS, Lin YC, Jan YY, Liau CT. Mitomycin C with weekly 24-h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract and periampullar carcinomas. Anticancer Drugs 2001; 12: 339-343
    • (2001) Anticancer Drugs , vol.12 , pp. 339-343
    • Chen, J.S.1    Lin, Y.C.2    Jan, Y.Y.3    Liau, C.T.4
  • 51
    • 0038312231 scopus 로고    scopus 로고
    • Phase II study of cisplatin, epirubicin, and continuous-infusion 5-fluorouracil for advanced biliary tract cancer
    • Morizane C, Okada S, Okusaka T, Ueno H, Saisho T. Phase II study of cisplatin, epirubicin, and continuous-infusion 5-fluorouracil for advanced biliary tract cancer. Oncology 2003; 64: 475-476
    • (2003) Oncology , vol.64 , pp. 475-476
    • Morizane, C.1    Okada, S.2    Okusaka, T.3    Ueno, H.4    Saisho, T.5
  • 53
    • 0036668659 scopus 로고    scopus 로고
    • Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma
    • Taïeb J, Mitry E, Boige V, Artru P, Ezenfis J, Lecomte T, Clavero-Fabri MC, Vaillant JN, Rougier P, Ducreux M. Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma. Ann Oncol 2002; 13: 1192-1196
    • (2002) Ann Oncol , vol.13 , pp. 1192-1196
    • Taïeb, J.1    Mitry, E.2    Boige, V.3    Artru, P.4    Ezenfis, J.5    Lecomte, T.6    Clavero-Fabri, M.C.7    Vaillant, J.N.8    Rougier, P.9    Ducreux, M.10
  • 56
    • 21044445124 scopus 로고    scopus 로고
    • The efficacy of epirubicin, cisplatin, uracil/tegafur, and leucovorin in patients with advanced biliary tract carcinoma
    • Park KH, Choi IK, Kim SJ, Oh SC, Seo JH, Choi CW, Kim BS, Shin SW, Kim YH, Kim JS. The efficacy of epirubicin, cisplatin, uracil/tegafur, and leucovorin in patients with advanced biliary tract carcinoma. Cancer 2005; 103: 2338-2343
    • (2005) Cancer , vol.103 , pp. 2338-2343
    • Park, K.H.1    Choi, I.K.2    Kim, S.J.3    Oh, S.C.4    Seo, J.H.5    Choi, C.W.6    Kim, B.S.7    Shin, S.W.8    Kim, Y.H.9    Kim, J.S.10
  • 57
    • 30744449247 scopus 로고    scopus 로고
    • Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinoma
    • Park SH, Park YH, Lee JN, Bang SM, Cho EK, Shin DB, Lee JH. Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinoma. Cancer 2006; 106: 361-365
    • (2006) Cancer , vol.106 , pp. 361-365
    • Park, S.H.1    Park, Y.H.2    Lee, J.N.3    Bang, S.M.4    Cho, E.K.5    Shin, D.B.6    Lee, J.H.7
  • 58
    • 0032526183 scopus 로고    scopus 로고
    • A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma
    • Sanz-Altamira PM, Ferrante K, Jenkins RL, Lewis WD, Huberman MS, Stuart KE. A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma. Cancer 1998; 82: 2321-2325
    • (1998) Cancer , vol.82 , pp. 2321-2325
    • Sanz-Altamira, P.M.1    Ferrante, K.2    Jenkins, R.L.3    Lewis, W.D.4    Huberman, M.S.5    Stuart, K.E.6
  • 59
    • 0037163665 scopus 로고    scopus 로고
    • Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective Phase II trial
    • Nehls O, Klump B, Arkenau HT, Hass HG, Greschniok A, Gregor M, Porschen R. Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective Phase II trial. Br J Cancer 2002; 87: 702-704
    • (2002) Br J Cancer , vol.87 , pp. 702-704
    • Nehls, O.1    Klump, B.2    Arkenau, H.T.3    Hass, H.G.4    Greschniok, A.5    Gregor, M.6    Porschen, R.7
  • 60
    • 0036021237 scopus 로고    scopus 로고
    • Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangio-carcinomas
    • Kuhn R, Hribaschek A, Eichelmann K, Rudolph S, Fahlke J, Ridwelski K. Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangio-carcinomas. Invest New Drugs 2002; 20: 351-356
    • (2002) Invest New Drugs , vol.20 , pp. 351-356
    • Kuhn, R.1    Hribaschek, A.2    Eichelmann, K.3    Rudolph, S.4    Fahlke, J.5    Ridwelski, K.6
  • 61
    • 2642567052 scopus 로고    scopus 로고
    • Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience
    • Knox JJ, Hedley D, Oza A, Siu LL, Pond GR, Moore MJ. Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience. Ann Oncol 2004; 15: 770-774
    • (2004) Ann Oncol , vol.15 , pp. 770-774
    • Knox, J.J.1    Hedley, D.2    Oza, A.3    Siu, L.L.4    Pond, G.R.5    Moore, M.J.6
  • 62
    • 2642516411 scopus 로고    scopus 로고
    • Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract
    • Hsu C, Shen YC, Yang CH, Yeh KH, Lu YS, Hsu CH, Liu HT, Li CC, Chen JS, Wu CY, Cheng AL. Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract. Br J Cancer 2004; 90: 1715-1719
    • (2004) Br J Cancer , vol.90 , pp. 1715-1719
    • Hsu, C.1    Shen, Y.C.2    Yang, C.H.3    Yeh, K.H.4    Lu, Y.S.5    Hsu, C.H.6    Liu, H.T.7    Li, C.C.8    Chen, J.S.9    Wu, C.Y.10    Cheng, A.L.11
  • 65
    • 29144480045 scopus 로고    scopus 로고
    • Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma
    • Cho JY, Paik YH, Chang YS, Lee SJ, Lee DK, Song SY, Chung JB, Park MS, Yu JS, Yoon DS. Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma. Cancer 2005; 104: 2753-2758
    • (2005) Cancer , vol.104 , pp. 2753-2758
    • Cho, J.Y.1    Paik, Y.H.2    Chang, Y.S.3    Lee, S.J.4    Lee, D.K.5    Song, S.Y.6    Chung, J.B.7    Park, M.S.8    Yu, J.S.9    Yoon, D.S.10
  • 66
    • 2442423894 scopus 로고    scopus 로고
    • A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer
    • Doval DC, Sekhon JS, Gupta SK, Fuloria J, Shukla VK, Gupta S, Awasthy BS. A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer. Br J Cancer 2004; 90: 1516-1520
    • (2004) Br J Cancer , vol.90 , pp. 1516-1520
    • Doval, D.C.1    Sekhon, J.S.2    Gupta, S.K.3    Fuloria, J.4    Shukla, V.K.5    Gupta, S.6    Awasthy, B.S.7
  • 67
    • 14644410398 scopus 로고    scopus 로고
    • Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma
    • Thongprasert S, Napapan S, Charoentum C, Moonprakan S. Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma. Ann Oncol 2005; 16: 279-281
    • (2005) Ann Oncol , vol.16 , pp. 279-281
    • Thongprasert, S.1    Napapan, S.2    Charoentum, C.3    Moonprakan, S.4
  • 71
    • 84890505257 scopus 로고    scopus 로고
    • General rules for the clinical and pathological study of primary liver cancer
    • Liver Cancer Study Group of Japan, Tokyo: Kanehara
    • Liver Cancer Study Group of Japan. General rules for the clinical and pathological study of primary liver cancer. Second English Edition. Tokyo: Kanehara; 2003
    • (2003) Second English Edition
  • 72
    • 7044264264 scopus 로고    scopus 로고
    • Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study
    • Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 2004; 127: 1372-80
    • (2004) Gastroenterology , vol.127 , pp. 1372-80
    • Davila, J.A.1    Morgan, R.O.2    Shaib, Y.3    McGlynn, K.A.4    El-Serag, H.B.5
  • 74
    • 53549093881 scopus 로고    scopus 로고
    • Patient with advanced intrahepatic cholangiocarcinoma with long-term survival successfully treated with a combination of surgery and chemotherapy
    • Morise Z, Sugioka A, Hoshimoto S, Kato T, Tanahashi Y, Ikeda M, Kagawa T. Patient with advanced intrahepatic cholangiocarcinoma with long-term survival successfully treated with a combination of surgery and chemotherapy. J Hepatobiliary Pancreat Surg 2008; 15: 545-548
    • (2008) J Hepatobiliary Pancreat Surg , vol.15 , pp. 545-548
    • Morise, Z.1    Sugioka, A.2    Hoshimoto, S.3    Kato, T.4    Tanahashi, Y.5    Ikeda, M.6    Kagawa, T.7
  • 75
    • 67650021895 scopus 로고    scopus 로고
    • Treatment of patients with unresectable advanced carcinoma of biliary tract -chemotherapy and surgical resection
    • Morise Z, Sugioka A, Tanahashi Y, Okabe Y, Ikeda M, Kagawa T, Takeura C. Treatment of patients with unresectable advanced carcinoma of biliary tract -chemotherapy and surgical resection. Anticancer Res 2009; 29: 1783-1786
    • (2009) Anticancer Res , vol.29 , pp. 1783-1786
    • Morise, Z.1    Sugioka, A.2    Tanahashi, Y.3    Okabe, Y.4    Ikeda, M.5    Kagawa, T.6    Takeura, C.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.